Technescan Maa is a radiopharmaceutical used in nuclear medicine imaging procedures to evaluate the perfusion of the liver and spleen. It is a sterile, pyrogen-free kit that contains a lyophilized powder of macroaggregated albumin (MAA) labeled with technetium-99m.
This imaging agent is administered intravenously and allows for the visualization of blood flow within the liver and spleen, aiding in the diagnosis and management of various liver and spleen disorders. Technescan Maa is particularly useful in assessing liver function, detecting liver tumors, and evaluating portal hypertension.
As with any radiopharmaceutical, Technescan Maa should be handled and administered by trained professionals in a controlled environment. Patients should be informed about the procedure and any potential risks associated with the use of this imaging agent.
It is important to note that Technescan Maa is contraindicated in patients with a known hypersensitivity to albumin or any of the components of the kit. Additionally, pregnant or breastfeeding women should not undergo imaging procedures using this radiopharmaceutical unless absolutely necessary.
Overall, Technescan Maa is a valuable tool in nuclear medicine imaging that provides important information about liver and spleen perfusion. As a medical professional, it is essential to understand the indications, contraindications, and proper administration of this drug to ensure the safety and well-being of our patients.
EN 
ES 
FR 
PT 
ZH